05.24.18
Deerland Enzymes, Kennesaw, GA, an international enzyme and probiotic-based dietary supplement formulator and contract manufacturer, welcomed Sam Michini to the company as vice president of marketing and strategy.
Mr. Michini joins Deerland with more than 25 years of experience in the pharmaceutical, vitamin, mineral and supplement industry. Most recently, he served as the vice president of sales, marketing and new product development for Delavau Pharmaceutical Partners in Philadelphia, PA. Prior to Delavau, he led commercialization and corporate strategy efforts for Dakota Life Sciences as executive vice president and chief commercial officer. Mr. Michini holds a degree in Communication from Niagara University.
Scott Ravech, CEO of Deerland, stated, “I’m excited for Sam to join our team; he’s a proven leader in creating and implementing growth strategies across both dietary supplement and pharmaceutical platforms. The diversity of his experience in these areas will undoubtedly help Deerland sustain the significant growth that we’ve experienced over the past decade.”
Mr. Michini joins Deerland with more than 25 years of experience in the pharmaceutical, vitamin, mineral and supplement industry. Most recently, he served as the vice president of sales, marketing and new product development for Delavau Pharmaceutical Partners in Philadelphia, PA. Prior to Delavau, he led commercialization and corporate strategy efforts for Dakota Life Sciences as executive vice president and chief commercial officer. Mr. Michini holds a degree in Communication from Niagara University.
Scott Ravech, CEO of Deerland, stated, “I’m excited for Sam to join our team; he’s a proven leader in creating and implementing growth strategies across both dietary supplement and pharmaceutical platforms. The diversity of his experience in these areas will undoubtedly help Deerland sustain the significant growth that we’ve experienced over the past decade.”
